Tag Archive for: Kalm Therapeutics

Kalm Therapeutics Wins $100,000 in Alabama Launchpad Life Sciences Track

Alabama Launchpad, a program of the Economic Development Partnership of Alabama (EDPA) in partnership with Innovate Alabama, has announced Kalm Therapeutics as the winner of $100,000 in non-dilutive funding in the Life Sciences Track. AJ Singhal, founder of Kalm Therapeutics, will receive $100,000 in non-dilutive funding, as well as access to follow-on mentorship and exposure […]

Kalm Therapeutics Gains Key Advisor as It Advances Clinical Pipeline

Kalm Therapeutics, a biotechnology firm based at the HudsonAlpha Institute for Biotechnology in Huntsville, said it has added Dr. Peter Lio, a Harvard-trained dermatologist and researcher, as both an investor and member of its Scientific Advisory Board. The move marks a key step for the company as it advances clinical development of its experimental patch […]

Kalm Therapeutics receives grant to advance steroid alternative research

Kalm Therapeutics’ effort to find an alternative to steroids used to combat conditions such as eczema and psoriasis received a boost in the form of what the company termed a “significant’’ grant. The grant was awarded by Southern Research’s Therapeutics Development Fund (TDF) and could hasten Kalm Therapeutics’ research. “The awarded grant will enable Kalm […]

CFD announces new start-up focused on groundbreaking eczema treatment

HUNTSVILLE, AL – CFD Research Corporation (CFD) announced the formation of Kalm Therapeutics (Kalm Tx) this week to bring a much-needed non-steroidal eczema treatment to patients with mild to moderate atopic dermatitis. The condition affects more than 16 million people in the United States. “After several years of research and development, it is rewarding to […]